O'Hara Elaine 4
4 · NOVAVAX INC · Filed Mar 4, 2025
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
O'Hara Elaine
EVP, Chief Strategy Officer
Transactions
- Tax Payment
Common Stock
2025-03-01$8.33/sh−5,375$44,774→ 68,450 total - Tax Payment
Common Stock
2025-03-01$8.33/sh−10,969$91,372→ 57,481 total - Exercise/Conversion
Common Stock
2025-03-01+19,600→ 33,825 total - Exercise/Conversion
Common Stock
2025-03-01+40,000→ 73,825 total - Exercise/Conversion
Restricted Stock Units
2025-03-01−40,000→ 80,000 totalExercise: $0.00Exp: 2034-03-01→ Common Stock (40,000 underlying) - Exercise/Conversion
Restricted Stock Units
2025-03-01−19,600→ 19,600 totalExercise: $0.00Exp: 2033-03-01→ Common Stock (19,600 underlying)
Footnotes (1)
- [F1]One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.